$0.42 EPS Expected for CONMED Corporation (CNMD)

July 17, 2017 - By wolcottdaily

 $0.42 EPS Expected for CONMED Corporation (CNMD)
Investors sentiment increased to 0.97 in 2016 Q4. Its up 0.12, from 0.85 in 2016Q3. It is positive, as 12 investors sold CONMED Corporation shares while 48 reduced holdings. 17 funds opened positions while 41 raised stakes. 26.92 million shares or 2.31% less from 27.56 million shares in 2016Q3 were reported.
Swiss Bankshares stated it has 0% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Zurcher Kantonalbank (Zurich Cantonalbank) reported 714 shares or 0% of all its holdings. Granahan Mngmt Ma holds 0.73% or 481,425 shares in its portfolio. 12,703 are owned by Arizona State Retirement Systems. Ww Invsts holds 1.11M shares or 0.01% of its portfolio. Alliancebernstein L P stated it has 45,067 shares or 0% of all its holdings. Vanguard Inc holds 2.18M shares or 0.01% of its portfolio. Krensavage Asset Limited Liability Co invested in 328,677 shares or 5.21% of the stock. Americafirst Mngmt Llc owns 4,833 shares for 0% of their portfolio. Ls Advisors Limited Liability accumulated 0% or 1,039 shares. California-based Huber Mgmt Lc has invested 0.66% in CONMED Corporation (NASDAQ:CNMD). Bessemer Gru owns 0% invested in CONMED Corporation (NASDAQ:CNMD) for 406 shares. Voya Investment Mgmt Limited Com has invested 0% in CONMED Corporation (NASDAQ:CNMD). Lord Abbett And Lc has invested 0.06% of its portfolio in CONMED Corporation (NASDAQ:CNMD). Continental Advsrs Lc has invested 0.22% of its portfolio in CONMED Corporation (NASDAQ:CNMD).

Since March 6, 2017, it had 4 insider buys, and 2 selling transactions for $347,557 activity. On Friday, March 10 the insider Hartman Curt R bought $322,115. On Monday, April 3 the insider Farkas Charles bought $7,994. 440 shares were bought by Cohen Heather L, worth $17,598. Shares for $52,239 were sold by Kuyper Dirk on Tuesday, June 13. JONAS DANIEL also sold $153,661 worth of CONMED Corporation (NASDAQ:CNMD) on Monday, May 15. TRYNISKI MARK E bought 5,000 shares worth $205,750.

Wall Street await CONMED Corporation (NASDAQ:CNMD) to release earnings on July, 26. Analysts forecast EPS of $0.42, down exactly $0.05 or 10.64 % from 2014’s $0.47 EPS. The expected CNMD’s profit could reach $11.73M giving the stock 30.27 P/E in the case that $0.42 earnings per share is reported. After posting $0.38 EPS for the previous quarter, CONMED Corporation’s analysts now forecast 10.53 % EPS growth. The stock increased 0.20% or $0.1 during the last trading session, reaching $50.85. About 75,914 shares traded. CONMED Corporation (NASDAQ:CNMD) has risen 27.59% since July 18, 2016 and is uptrending. It has outperformed by 10.89% the S&P500.

CONMED Corporation (NASDAQ:CNMD) Ratings Coverage

Among 4 analysts covering CONMED Corporation (NASDAQ:CNMD), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. CONMED Corporation had 9 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, April 28 by Needham. Piper Jaffray maintained CONMED Corporation (NASDAQ:CNMD) on Thursday, August 27 with “Neutral” rating. The firm has “Market Perform” rating given on Wednesday, July 22 by Northland Capital. The firm has “Market Perform” rating by Northland Capital given on Thursday, October 22. As per Monday, October 12, the company rating was upgraded by Ladenburg Thalmann. Leerink Swann maintained CONMED Corporation (NASDAQ:CNMD) on Monday, October 5 with “Outperform” rating. Needham maintained it with “Buy” rating and $53 target in Friday, November 18 report.

CONMED Corporation is a medical technology company. The company has market cap of $1.42 billion. The Firm is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. It has a 115.03 P/E ratio. The Firm provides surgical devices and equipment for minimally invasive procedures.

More recent CONMED Corporation (NASDAQ:CNMD) news were published by: Reuters.com which released: “BRIEF-MedShape sells ExoShape ACL product line to CONMED Corp” on July 05, 2017. Also Businesswire.com published the news titled: “CONMED Corporation to Announce Second Quarter 2017 Financial Results on July …” on July 10, 2017. Prnewswire.com‘s news article titled: “MedShape Sells ExoShape┬« ACL Product Line to CONMED Corporation” with publication date: July 05, 2017 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.